Routine use of narrow band imaging in screening colonoscopy does not increase the adenoma detection rate, finds a study in Clinical Gastroenterology and Hepatology.
Both amitriptyline and placebo are associated with an excellent therapeutic response in children with functional gastrointestinal disorders, finds a study in the October issue of Gastroenterology.
Pancreatectomies for chronic pancreatitis have lower in-hospital mortality than those performed for malignancy, finds a study in the Journal of the American College of Surgeons.
A study in the latest Alimentary Pharmacology and Therapeutics finds high therapy adherence but substantial limitations to daily activities in Dutch inflammatory bowel disease patients.
Reducing mortality associated with inpatient surgery requires greater attention to the timely recognition and management of complications once they occur, finds a study in the New England Journal of Medicine.
Endoscopist-directed propofol sedation has a mortality rate comparable to that in the published data on general anesthesia by anesthesiologists, finds a study in Gastroenterology.
A meta-analysis in Neurogastroenterology and Theraputics finds that biofeedback therapy for pelvic floor dyssynergia shows substantial specific therapeutic effect.
Patients with moderate to severe ulcerative colitis treated with infliximab are less likely to undergo colectomy, finds a study in the October issue of Gastroenterology.
A study in the latest issue of Alimentary Pharmacology and Therapeutics finds a modest rise in the incidence of esophageal adenocarcinoma and junctional/cardia adenocarcinoma in a UK population.
The most recent issue of the American Journal of Gastroenterology assesses the extent and determinants of prescribing and adherence with acid-reducing medications.
The most recent issue of the Alimentary Pharmacology & Therapeutics evaluates recent incidence trends and sociodemographic features of esophageal and gastric cancer types in an English region.
Propofol sedation for upper GI endoscopy in patients with liver cirrhosis is an alternative to midazolam to avoid acute deterioration of minimal encephalopathy, reports the latest issue of Scandanavian Journal of Gastroenterology.
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .